Drug General Information |
Drug ID |
D0D9BB
|
Former ID |
DNC007709
|
Drug Name |
1-benzhydryl-4-(pyridin-2-yl)piperidin-4-ol
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C23H24N2O
|
Canonical SMILES |
C1CN(CCC1(C2=CC=CC=N2)O)C(C3=CC=CC=C3)C4=CC=CC=C4
|
InChI |
1S/C23H24N2O/c26-23(21-13-7-8-16-24-21)14-17-25(18-15-23)22(19-9-3-1-4-10-19)20-11-5-2-6-12-20/h1-13,16,22,26H,14-15,17-18H2
|
InChIKey |
RQPLUPANAPAMMF-UHFFFAOYSA-N
|
PubChem Compound ID |
|
Target and Pathway |
Target(s) |
Kappa-type opioid receptor |
Target Info |
Inhibitor |
[1]
|
Nociceptin receptor |
Target Info |
Inhibitor |
[1]
|
Mu-type opioid receptor |
Target Info |
Inhibitor |
[1]
|
KEGG Pathway
|
Neuroactive ligand-receptor interactionhsa04080:Neuroactive ligand-receptor interactionhsa04080:Neuroactive ligand-receptor interaction
|
Estrogen signaling pathway
|
Morphine addiction
|
NetPath Pathway
|
TCR Signaling Pathway
|
PANTHER Pathway
|
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
|
Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
Enkephalin release
|
Pathway Interaction Database
|
IL4-mediated signaling events
|
Reactome
|
Peptide ligand-binding receptors
|
G alpha (i) signalling eventsR-HSA-375276:Peptide ligand-binding receptors
|
G alpha (i) signalling events
|
WikiPathways
|
GPCRs, Class A Rhodopsin-like
|
Peptide GPCRs
|
GPCR ligand binding
|
GPCR downstream signalingWP455:GPCRs, Class A Rhodopsin-like
|
GPCR downstream signalingWP69:TCR Signaling Pathway
|
Opioid Signalling
|
GPCR downstream signaling
|
References |
REF 1 | Bioorg Med Chem Lett. 2007 Jun 1;17(11):3028-33. Epub 2007 Mar 21.Synthesis and structure-activity relationships of 4-hydroxy-4-phenylpiperidines as nociceptin receptor ligands: Part 2. |